nodes	percent_of_prediction	percent_of_DWPC	metapath
Everolimus—MTOR—neck—salivary gland cancer	0.0138	0.164	CbGeAlD
Everolimus—FKBP1A—neck—salivary gland cancer	0.0124	0.147	CbGeAlD
Everolimus—MTOR—connective tissue—salivary gland cancer	0.00991	0.117	CbGeAlD
Everolimus—MTOR—epithelium—salivary gland cancer	0.00941	0.111	CbGeAlD
Everolimus—FKBP1A—connective tissue—salivary gland cancer	0.00891	0.106	CbGeAlD
Everolimus—FKBP1A—epithelium—salivary gland cancer	0.00846	0.1	CbGeAlD
Everolimus—MTOR—lymphoid tissue—salivary gland cancer	0.00724	0.0858	CbGeAlD
Everolimus—FKBP1A—lymphoid tissue—salivary gland cancer	0.00652	0.0772	CbGeAlD
Everolimus—MTOR—lymph node—salivary gland cancer	0.00409	0.0484	CbGeAlD
Everolimus—FKBP1A—lymph node—salivary gland cancer	0.00368	0.0435	CbGeAlD
Everolimus—FKBP1A—Signaling Pathways—WNT5B—salivary gland cancer	0.00154	0.00168	CbGpPWpGaD
Everolimus—FKBP1A—Disease—DTX4—salivary gland cancer	0.00151	0.00165	CbGpPWpGaD
Everolimus—MTOR—ErbB Signaling Pathway—HRAS—salivary gland cancer	0.00151	0.00165	CbGpPWpGaD
Everolimus—FKBP1A—Spinal Cord Injury—TP53—salivary gland cancer	0.0015	0.00164	CbGpPWpGaD
Everolimus—FKBP1A—Integrated Pancreatic Cancer Pathway—PTEN—salivary gland cancer	0.0015	0.00163	CbGpPWpGaD
Everolimus—MTOR—NGF signalling via TRKA from the plasma membrane—MAP2K2—salivary gland cancer	0.00149	0.00163	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—IL17RD—salivary gland cancer	0.00149	0.00162	CbGpPWpGaD
Everolimus—MTOR—IL4-mediated signaling events—PIK3CA—salivary gland cancer	0.00146	0.0016	CbGpPWpGaD
Everolimus—MTOR—PI-3K cascade—PTEN—salivary gland cancer	0.00144	0.00157	CbGpPWpGaD
Everolimus—MTOR—Innate Immune System—CYLD—salivary gland cancer	0.00143	0.00156	CbGpPWpGaD
Everolimus—FKBP1A—Integrated Pancreatic Cancer Pathway—EP300—salivary gland cancer	0.00143	0.00156	CbGpPWpGaD
Everolimus—MTOR—Integrated Breast Cancer Pathway—CDH1—salivary gland cancer	0.00141	0.00154	CbGpPWpGaD
Everolimus—MTOR—Signaling by NGF—FOXO3—salivary gland cancer	0.00141	0.00154	CbGpPWpGaD
Everolimus—MTOR—PI3K/AKT activation—PTEN—salivary gland cancer	0.0014	0.00153	CbGpPWpGaD
Everolimus—MTOR—GAB1 signalosome—PTEN—salivary gland cancer	0.00139	0.00152	CbGpPWpGaD
Everolimus—MTOR—TSH signaling pathway—PIK3CA—salivary gland cancer	0.00139	0.00152	CbGpPWpGaD
Everolimus—MTOR—Innate Immune System—PRKDC—salivary gland cancer	0.00137	0.0015	CbGpPWpGaD
Everolimus—MTOR—Oncostatin M Signaling Pathway—TP53—salivary gland cancer	0.00136	0.00149	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—MAML3—salivary gland cancer	0.00136	0.00149	CbGpPWpGaD
Everolimus—MTOR—Role of LAT2/NTAL/LAB on calcium mobilization—PTEN—salivary gland cancer	0.00136	0.00148	CbGpPWpGaD
Everolimus—MTOR—Senescence and Autophagy in Cancer—PTEN—salivary gland cancer	0.00136	0.00148	CbGpPWpGaD
Everolimus—MTOR—Costimulation by the CD28 family—PIK3CA—salivary gland cancer	0.00136	0.00148	CbGpPWpGaD
Everolimus—MTOR—PI3K Cascade—PIK3CA—salivary gland cancer	0.00136	0.00148	CbGpPWpGaD
Everolimus—MTOR—AMPK Signaling—PIK3CA—salivary gland cancer	0.00134	0.00146	CbGpPWpGaD
Everolimus—MTOR—SREBP signalling—PIK3CA—salivary gland cancer	0.00134	0.00146	CbGpPWpGaD
Everolimus—MTOR—CDC42 signaling events—PIK3CA—salivary gland cancer	0.00133	0.00145	CbGpPWpGaD
Everolimus—MTOR—Innate Immune System—FGF16—salivary gland cancer	0.00131	0.00143	CbGpPWpGaD
Everolimus—MTOR—Oncostatin M Signaling Pathway—HRAS—salivary gland cancer	0.0013	0.00142	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—ERBB2IP—salivary gland cancer	0.0013	0.00142	CbGpPWpGaD
Everolimus—MTOR—AMPK Signaling—TP53—salivary gland cancer	0.0013	0.00142	CbGpPWpGaD
Everolimus—MTOR—TSH signaling pathway—HRAS—salivary gland cancer	0.00129	0.0014	CbGpPWpGaD
Everolimus—MTOR—mTOR signaling pathway—HRAS—salivary gland cancer	0.00129	0.0014	CbGpPWpGaD
Everolimus—MTOR—Adaptive Immune System—FGF16—salivary gland cancer	0.00126	0.00137	CbGpPWpGaD
Everolimus—FKBP1A—Disease—FGF16—salivary gland cancer	0.00125	0.00137	CbGpPWpGaD
Everolimus—MTOR—Disease—WNT5B—salivary gland cancer	0.00124	0.00135	CbGpPWpGaD
Everolimus—MTOR—CDC42 signaling events—HRAS—salivary gland cancer	0.00123	0.00134	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—MC3R—salivary gland cancer	0.00121	0.00132	CbGpPWpGaD
Everolimus—FKBP1A—Disease—NUP62—salivary gland cancer	0.0012	0.00131	CbGpPWpGaD
Everolimus—MTOR—Disease—IL17RD—salivary gland cancer	0.00119	0.0013	CbGpPWpGaD
Everolimus—MTOR—Disease—PYGB—salivary gland cancer	0.00119	0.0013	CbGpPWpGaD
Everolimus—MTOR—Disease—CPSF4—salivary gland cancer	0.00119	0.0013	CbGpPWpGaD
Everolimus—MTOR—Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met)—PIK3CA—salivary gland cancer	0.00119	0.0013	CbGpPWpGaD
Everolimus—FKBP1A—Disease—VCAN—salivary gland cancer	0.00119	0.0013	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—ST3GAL4—salivary gland cancer	0.00117	0.00127	CbGpPWpGaD
Everolimus—MTOR—Leptin signaling pathway—HRAS—salivary gland cancer	0.00116	0.00127	CbGpPWpGaD
Everolimus—MTOR—Signaling by NGF—MAP2K2—salivary gland cancer	0.00115	0.00125	CbGpPWpGaD
Everolimus—MTOR—CXCR4-mediated signaling events—PIK3CA—salivary gland cancer	0.00115	0.00125	CbGpPWpGaD
Everolimus—MTOR—MicroRNAs in cardiomyocyte hypertrophy—PIK3CA—salivary gland cancer	0.00115	0.00125	CbGpPWpGaD
Everolimus—MTOR—IRS-mediated signalling—PIK3CA—salivary gland cancer	0.00114	0.00124	CbGpPWpGaD
Everolimus—MTOR—Constitutive PI3K/AKT Signaling in Cancer—PIK3CA—salivary gland cancer	0.00112	0.00123	CbGpPWpGaD
Everolimus—MTOR—IRS-related events—PIK3CA—salivary gland cancer	0.0011	0.00121	CbGpPWpGaD
Everolimus—MTOR—Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met)—HRAS—salivary gland cancer	0.0011	0.0012	CbGpPWpGaD
Everolimus—MTOR—IRS-related events triggered by IGF1R—PIK3CA—salivary gland cancer	0.00109	0.00119	CbGpPWpGaD
Everolimus—MTOR—Disease—MAML3—salivary gland cancer	0.00109	0.00119	CbGpPWpGaD
Everolimus—FKBP1A—Disease—MAML2—salivary gland cancer	0.00109	0.00119	CbGpPWpGaD
Everolimus—MTOR—Signaling by SCF-KIT—PTEN—salivary gland cancer	0.00107	0.00117	CbGpPWpGaD
Everolimus—MTOR—IGF1R signaling cascade—PIK3CA—salivary gland cancer	0.00107	0.00116	CbGpPWpGaD
Everolimus—MTOR—Insulin receptor signalling cascade—PIK3CA—salivary gland cancer	0.00107	0.00116	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—DTX4—salivary gland cancer	0.00106	0.00116	CbGpPWpGaD
Everolimus—FKBP1A—Integrated Pancreatic Cancer Pathway—PIK3CA—salivary gland cancer	0.00106	0.00115	CbGpPWpGaD
Everolimus—MTOR—Integrated Breast Cancer Pathway—CCND1—salivary gland cancer	0.00105	0.00115	CbGpPWpGaD
Everolimus—MTOR—IRS-mediated signalling—HRAS—salivary gland cancer	0.00105	0.00115	CbGpPWpGaD
Everolimus—MTOR—Cellular responses to stress—ATM—salivary gland cancer	0.00105	0.00114	CbGpPWpGaD
Everolimus—MTOR—Downstream signaling of activated FGFR—PTEN—salivary gland cancer	0.00103	0.00112	CbGpPWpGaD
Everolimus—FKBP1A—Integrated Pancreatic Cancer Pathway—TP53—salivary gland cancer	0.00102	0.00112	CbGpPWpGaD
Everolimus—MTOR—IRS-related events—HRAS—salivary gland cancer	0.00102	0.00112	CbGpPWpGaD
Everolimus—MTOR—Integrated Breast Cancer Pathway—PTEN—salivary gland cancer	0.00102	0.00111	CbGpPWpGaD
Everolimus—MTOR—PI-3K cascade—PIK3CA—salivary gland cancer	0.00101	0.00111	CbGpPWpGaD
Everolimus—MTOR—IRS-related events triggered by IGF1R—HRAS—salivary gland cancer	0.00101	0.00111	CbGpPWpGaD
Everolimus—MTOR—Signaling by ERBB4—PTEN—salivary gland cancer	0.00101	0.0011	CbGpPWpGaD
Everolimus—MTOR—PI3K/AKT activation—PIK3CA—salivary gland cancer	0.000989	0.00108	CbGpPWpGaD
Everolimus—MTOR—Insulin receptor signalling cascade—HRAS—salivary gland cancer	0.000986	0.00108	CbGpPWpGaD
Everolimus—MTOR—IGF1R signaling cascade—HRAS—salivary gland cancer	0.000986	0.00108	CbGpPWpGaD
Everolimus—MTOR—GAB1 signalosome—PIK3CA—salivary gland cancer	0.000981	0.00107	CbGpPWpGaD
Everolimus—MTOR—Insulin Signaling—PTEN—salivary gland cancer	0.00097	0.00106	CbGpPWpGaD
Everolimus—MTOR—Integrated Breast Cancer Pathway—EP300—salivary gland cancer	0.000969	0.00106	CbGpPWpGaD
Everolimus—MTOR—Innate Immune System—FGFR4—salivary gland cancer	0.000967	0.00106	CbGpPWpGaD
Everolimus—MTOR—Downstream signal transduction—PTEN—salivary gland cancer	0.000965	0.00105	CbGpPWpGaD
Everolimus—MTOR—Signaling by FGFR—PTEN—salivary gland cancer	0.00096	0.00105	CbGpPWpGaD
Everolimus—MTOR—EGF/EGFR Signaling Pathway—PTEN—salivary gland cancer	0.00096	0.00105	CbGpPWpGaD
Everolimus—MTOR—Role of LAT2/NTAL/LAB on calcium mobilization—PIK3CA—salivary gland cancer	0.000958	0.00105	CbGpPWpGaD
Everolimus—MTOR—ErbB1 downstream signaling—PIK3CA—salivary gland cancer	0.000958	0.00105	CbGpPWpGaD
Everolimus—MTOR—Signaling by ERBB2—PTEN—salivary gland cancer	0.000956	0.00104	CbGpPWpGaD
Everolimus—MTOR—DAP12 signaling—PTEN—salivary gland cancer	0.000951	0.00104	CbGpPWpGaD
Everolimus—MTOR—VEGFA-VEGFR2 Pathway—PIK3CA—salivary gland cancer	0.000944	0.00103	CbGpPWpGaD
Everolimus—MTOR—Disease—ST3GAL4—salivary gland cancer	0.000937	0.00102	CbGpPWpGaD
Everolimus—MTOR—Downstream signaling events of B Cell Receptor (BCR)—PTEN—salivary gland cancer	0.000937	0.00102	CbGpPWpGaD
Everolimus—MTOR—Adaptive Immune System—FGFR4—salivary gland cancer	0.000929	0.00101	CbGpPWpGaD
Everolimus—FKBP1A—Disease—JAG1—salivary gland cancer	0.000929	0.00101	CbGpPWpGaD
Everolimus—MTOR—Senescence and Autophagy in Cancer—TP53—salivary gland cancer	0.000927	0.00101	CbGpPWpGaD
Everolimus—FKBP1A—Disease—FGFR4—salivary gland cancer	0.000925	0.00101	CbGpPWpGaD
Everolimus—MTOR—Immune System—DTX4—salivary gland cancer	0.000922	0.00101	CbGpPWpGaD
Everolimus—MTOR—Adaptive Immune System—FBXW7—salivary gland cancer	0.000914	0.000998	CbGpPWpGaD
Everolimus—MTOR—Cellular responses to stress—CREBBP—salivary gland cancer	0.00091	0.000994	CbGpPWpGaD
Everolimus—FKBP1A—Disease—FBXW7—salivary gland cancer	0.00091	0.000994	CbGpPWpGaD
Everolimus—MTOR—Signaling by FGFR in disease—PTEN—salivary gland cancer	0.000895	0.000977	CbGpPWpGaD
Everolimus—MTOR—DAP12 interactions—PTEN—salivary gland cancer	0.000895	0.000977	CbGpPWpGaD
Everolimus—MTOR—Fc epsilon receptor (FCERI) signaling—PTEN—salivary gland cancer	0.000895	0.000977	CbGpPWpGaD
Everolimus—MTOR—Signaling by VEGF—PIK3CA—salivary gland cancer	0.000891	0.000973	CbGpPWpGaD
Everolimus—MTOR—ErbB1 downstream signaling—HRAS—salivary gland cancer	0.000887	0.000969	CbGpPWpGaD
Everolimus—MTOR—Senescence and Autophagy in Cancer—HRAS—salivary gland cancer	0.000887	0.000969	CbGpPWpGaD
Everolimus—MTOR—Signaling by EGFR—PTEN—salivary gland cancer	0.000887	0.000968	CbGpPWpGaD
Everolimus—MTOR—Signaling by Insulin receptor—PIK3CA—salivary gland cancer	0.000885	0.000967	CbGpPWpGaD
Everolimus—MTOR—Signaling by EGFR in Cancer—PTEN—salivary gland cancer	0.000879	0.00096	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—FGF16—salivary gland cancer	0.000877	0.000958	CbGpPWpGaD
Everolimus—MTOR—Signaling by PDGF—PTEN—salivary gland cancer	0.000875	0.000956	CbGpPWpGaD
Everolimus—MTOR—VEGFA-VEGFR2 Pathway—HRAS—salivary gland cancer	0.000874	0.000954	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—WNT5B—salivary gland cancer	0.000866	0.000946	CbGpPWpGaD
Everolimus—MTOR—Disease—DTX4—salivary gland cancer	0.000851	0.00093	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—IL17RD—salivary gland cancer	0.000837	0.000914	CbGpPWpGaD
Everolimus—MTOR—Immune System—CYLD—salivary gland cancer	0.000834	0.000911	CbGpPWpGaD
Everolimus—MTOR—B Cell Activation—PTEN—salivary gland cancer	0.000828	0.000904	CbGpPWpGaD
Everolimus—MTOR—Signaling by VEGF—HRAS—salivary gland cancer	0.000825	0.000901	CbGpPWpGaD
Everolimus—MTOR—Signaling by Insulin receptor—HRAS—salivary gland cancer	0.000819	0.000894	CbGpPWpGaD
Everolimus—MTOR—Innate Immune System—FOXO3—salivary gland cancer	0.000803	0.000877	CbGpPWpGaD
Everolimus—MTOR—Immune System—PRKDC—salivary gland cancer	0.000799	0.000873	CbGpPWpGaD
Everolimus—MTOR—NGF signalling via TRKA from the plasma membrane—PTEN—salivary gland cancer	0.000792	0.000866	CbGpPWpGaD
Everolimus—MTOR—Adaptive Immune System—FOXO3—salivary gland cancer	0.000771	0.000842	CbGpPWpGaD
Everolimus—FKBP1A—Disease—FOXO3—salivary gland cancer	0.000767	0.000838	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—MAML3—salivary gland cancer	0.000765	0.000836	CbGpPWpGaD
Everolimus—MTOR—Immune System—FGF16—salivary gland cancer	0.000763	0.000833	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—MAML2—salivary gland cancer	0.000762	0.000832	CbGpPWpGaD
Everolimus—MTOR—Signaling by SCF-KIT—PIK3CA—salivary gland cancer	0.000757	0.000827	CbGpPWpGaD
Everolimus—MTOR—Immune System—NUP62—salivary gland cancer	0.000731	0.000799	CbGpPWpGaD
Everolimus—MTOR—Downstream signaling of activated FGFR—PIK3CA—salivary gland cancer	0.000724	0.000791	CbGpPWpGaD
Everolimus—MTOR—Signaling by ERBB4—PIK3CA—salivary gland cancer	0.000713	0.000779	CbGpPWpGaD
Everolimus—MTOR—Disease—FGF16—salivary gland cancer	0.000704	0.000769	CbGpPWpGaD
Everolimus—MTOR—Signaling by SCF-KIT—HRAS—salivary gland cancer	0.0007	0.000765	CbGpPWpGaD
Everolimus—MTOR—Integrated Breast Cancer Pathway—TP53—salivary gland cancer	0.000693	0.000757	CbGpPWpGaD
Everolimus—MTOR—BDNF signaling pathway—HRAS—salivary gland cancer	0.000689	0.000752	CbGpPWpGaD
Everolimus—MTOR—Insulin Signaling—PIK3CA—salivary gland cancer	0.000684	0.000747	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—MC3R—salivary gland cancer	0.000682	0.000745	CbGpPWpGaD
Everolimus—MTOR—Downstream signal transduction—PIK3CA—salivary gland cancer	0.000681	0.000744	CbGpPWpGaD
Everolimus—MTOR—Signaling by FGFR—PIK3CA—salivary gland cancer	0.000678	0.00074	CbGpPWpGaD
Everolimus—MTOR—Disease—NUP62—salivary gland cancer	0.000675	0.000737	CbGpPWpGaD
Everolimus—MTOR—Signaling by ERBB2—PIK3CA—salivary gland cancer	0.000674	0.000736	CbGpPWpGaD
Everolimus—MTOR—DAP12 signaling—PIK3CA—salivary gland cancer	0.000671	0.000733	CbGpPWpGaD
Everolimus—MTOR—Downstream signaling of activated FGFR—HRAS—salivary gland cancer	0.00067	0.000732	CbGpPWpGaD
Everolimus—MTOR—Disease—VCAN—salivary gland cancer	0.00067	0.000732	CbGpPWpGaD
Everolimus—MTOR—Downstream signaling events of B Cell Receptor (BCR)—PIK3CA—salivary gland cancer	0.000661	0.000722	CbGpPWpGaD
Everolimus—MTOR—Signaling by ERBB4—HRAS—salivary gland cancer	0.00066	0.00072	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—ST3GAL4—salivary gland cancer	0.000656	0.000717	CbGpPWpGaD
Everolimus—MTOR—Innate Immune System—MAP2K2—salivary gland cancer	0.000655	0.000716	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—JAG1—salivary gland cancer	0.00065	0.00071	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—FGFR4—salivary gland cancer	0.000647	0.000707	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—FBXW7—salivary gland cancer	0.000637	0.000696	CbGpPWpGaD
Everolimus—MTOR—Insulin Signaling—HRAS—salivary gland cancer	0.000633	0.000691	CbGpPWpGaD
Everolimus—MTOR—DAP12 interactions—PIK3CA—salivary gland cancer	0.000631	0.000689	CbGpPWpGaD
Everolimus—MTOR—Signaling by FGFR in disease—PIK3CA—salivary gland cancer	0.000631	0.000689	CbGpPWpGaD
Everolimus—MTOR—Fc epsilon receptor (FCERI) signaling—PIK3CA—salivary gland cancer	0.000631	0.000689	CbGpPWpGaD
Everolimus—MTOR—Downstream signal transduction—HRAS—salivary gland cancer	0.00063	0.000688	CbGpPWpGaD
Everolimus—MTOR—EGF/EGFR Signaling Pathway—HRAS—salivary gland cancer	0.000627	0.000685	CbGpPWpGaD
Everolimus—MTOR—Signaling by FGFR—HRAS—salivary gland cancer	0.000627	0.000685	CbGpPWpGaD
Everolimus—FKBP1A—Disease—MAP2K2—salivary gland cancer	0.000627	0.000684	CbGpPWpGaD
Everolimus—MTOR—Signaling by EGFR—PIK3CA—salivary gland cancer	0.000626	0.000683	CbGpPWpGaD
Everolimus—MTOR—Signaling by ERBB2—HRAS—salivary gland cancer	0.000624	0.000681	CbGpPWpGaD
Everolimus—MTOR—DAP12 signaling—HRAS—salivary gland cancer	0.000621	0.000678	CbGpPWpGaD
Everolimus—MTOR—Signaling by EGFR in Cancer—PIK3CA—salivary gland cancer	0.00062	0.000677	CbGpPWpGaD
Everolimus—MTOR—Cellular responses to stress—EP300—salivary gland cancer	0.00062	0.000677	CbGpPWpGaD
Everolimus—MTOR—Signaling by PDGF—PIK3CA—salivary gland cancer	0.000617	0.000674	CbGpPWpGaD
Everolimus—MTOR—Downstream signaling events of B Cell Receptor (BCR)—HRAS—salivary gland cancer	0.000612	0.000668	CbGpPWpGaD
Everolimus—MTOR—Disease—MAML2—salivary gland cancer	0.000612	0.000668	CbGpPWpGaD
Everolimus—MTOR—Signaling by NGF—PTEN—salivary gland cancer	0.000609	0.000666	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—DTX4—salivary gland cancer	0.000596	0.000651	CbGpPWpGaD
Everolimus—MTOR—B Cell Activation—PIK3CA—salivary gland cancer	0.000584	0.000638	CbGpPWpGaD
Everolimus—MTOR—Fc epsilon receptor (FCERI) signaling—HRAS—salivary gland cancer	0.000584	0.000638	CbGpPWpGaD
Everolimus—MTOR—DAP12 interactions—HRAS—salivary gland cancer	0.000584	0.000638	CbGpPWpGaD
Everolimus—MTOR—Signaling by FGFR in disease—HRAS—salivary gland cancer	0.000584	0.000638	CbGpPWpGaD
Everolimus—MTOR—Signaling by EGFR—HRAS—salivary gland cancer	0.000579	0.000632	CbGpPWpGaD
Everolimus—MTOR—Signaling by EGFR in Cancer—HRAS—salivary gland cancer	0.000574	0.000627	CbGpPWpGaD
Everolimus—MTOR—Signaling by PDGF—HRAS—salivary gland cancer	0.000571	0.000624	CbGpPWpGaD
Everolimus—MTOR—Immune System—FGFR4—salivary gland cancer	0.000563	0.000615	CbGpPWpGaD
Everolimus—MTOR—NGF signalling via TRKA from the plasma membrane—PIK3CA—salivary gland cancer	0.000559	0.000611	CbGpPWpGaD
Everolimus—MTOR—Immune System—FBXW7—salivary gland cancer	0.000554	0.000605	CbGpPWpGaD
Everolimus—MTOR—B Cell Activation—HRAS—salivary gland cancer	0.00054	0.00059	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—FOXO3—salivary gland cancer	0.000537	0.000587	CbGpPWpGaD
Everolimus—MTOR—Disease—JAG1—salivary gland cancer	0.000522	0.00057	CbGpPWpGaD
Everolimus—MTOR—Disease—FGFR4—salivary gland cancer	0.00052	0.000568	CbGpPWpGaD
Everolimus—MTOR—NGF signalling via TRKA from the plasma membrane—HRAS—salivary gland cancer	0.000517	0.000565	CbGpPWpGaD
Everolimus—FKBP1A—Disease—NOTCH1—salivary gland cancer	0.000513	0.000561	CbGpPWpGaD
Everolimus—MTOR—Disease—FBXW7—salivary gland cancer	0.000512	0.000559	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—FGF16—salivary gland cancer	0.000493	0.000539	CbGpPWpGaD
Everolimus—MTOR—Innate Immune System—CREBBP—salivary gland cancer	0.000487	0.000532	CbGpPWpGaD
Everolimus—MTOR—Immune System—FOXO3—salivary gland cancer	0.000467	0.000511	CbGpPWpGaD
Everolimus—FKBP1A—Disease—CREBBP—salivary gland cancer	0.000465	0.000508	CbGpPWpGaD
Everolimus—MTOR—Adaptive Immune System—CDH1—salivary gland cancer	0.000464	0.000507	CbGpPWpGaD
Everolimus—MTOR—Cellular responses to stress—TP53—salivary gland cancer	0.000443	0.000484	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—MAP2K2—salivary gland cancer	0.000439	0.000479	CbGpPWpGaD
Everolimus—MTOR—Disease—FOXO3—salivary gland cancer	0.000432	0.000471	CbGpPWpGaD
Everolimus—MTOR—Signaling by NGF—PIK3CA—salivary gland cancer	0.00043	0.00047	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—MAML2—salivary gland cancer	0.000428	0.000468	CbGpPWpGaD
Everolimus—MTOR—Signaling by NGF—HRAS—salivary gland cancer	0.000398	0.000435	CbGpPWpGaD
Everolimus—MTOR—Immune System—MAP2K2—salivary gland cancer	0.000382	0.000417	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—JAG1—salivary gland cancer	0.000366	0.000399	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—FGFR4—salivary gland cancer	0.000364	0.000398	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—NOTCH1—salivary gland cancer	0.000359	0.000393	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—FBXW7—salivary gland cancer	0.000358	0.000391	CbGpPWpGaD
Everolimus—MTOR—Disease—MAP2K2—salivary gland cancer	0.000352	0.000385	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—ISYNA1—salivary gland cancer	0.00035	0.000382	CbGpPWpGaD
Everolimus—MTOR—Innate Immune System—PTEN—salivary gland cancer	0.000348	0.00038	CbGpPWpGaD
Everolimus—MTOR—Adaptive Immune System—PTEN—salivary gland cancer	0.000334	0.000365	CbGpPWpGaD
Everolimus—FKBP1A—Disease—PTEN—salivary gland cancer	0.000332	0.000363	CbGpPWpGaD
Everolimus—MTOR—Innate Immune System—EP300—salivary gland cancer	0.000332	0.000362	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—CREBBP—salivary gland cancer	0.000326	0.000356	CbGpPWpGaD
Everolimus—FKBP1A—Disease—EP300—salivary gland cancer	0.000317	0.000346	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—FOXO3—salivary gland cancer	0.000302	0.00033	CbGpPWpGaD
Everolimus—MTOR—Disease—NOTCH1—salivary gland cancer	0.000289	0.000315	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—MARCKS—salivary gland cancer	0.000285	0.000312	CbGpPWpGaD
Everolimus—MTOR—Immune System—CREBBP—salivary gland cancer	0.000284	0.00031	CbGpPWpGaD
Everolimus—MTOR—Immune System—CDH1—salivary gland cancer	0.000281	0.000307	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—PYGB—salivary gland cancer	0.000265	0.00029	CbGpPWpGaD
Everolimus—MTOR—Disease—CREBBP—salivary gland cancer	0.000262	0.000286	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—MAP2K2—salivary gland cancer	0.000247	0.00027	CbGpPWpGaD
Everolimus—MTOR—Innate Immune System—PIK3CA—salivary gland cancer	0.000245	0.000268	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—CCND1—salivary gland cancer	0.000241	0.000263	CbGpPWpGaD
Everolimus—MTOR—Adaptive Immune System—PIK3CA—salivary gland cancer	0.000235	0.000257	CbGpPWpGaD
Everolimus—FKBP1A—Disease—PIK3CA—salivary gland cancer	0.000234	0.000256	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—PTEN—salivary gland cancer	0.000233	0.000254	CbGpPWpGaD
Everolimus—MTOR—Innate Immune System—HRAS—salivary gland cancer	0.000227	0.000248	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—EP300—salivary gland cancer	0.000222	0.000242	CbGpPWpGaD
Everolimus—MTOR—Adaptive Immune System—HRAS—salivary gland cancer	0.000218	0.000238	CbGpPWpGaD
Everolimus—FKBP1A—Disease—HRAS—salivary gland cancer	0.000217	0.000237	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—PHGDH—salivary gland cancer	0.000216	0.000236	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—ST3GAL4—salivary gland cancer	0.000208	0.000227	CbGpPWpGaD
Everolimus—MTOR—Immune System—PTEN—salivary gland cancer	0.000202	0.000221	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—NOTCH1—salivary gland cancer	0.000202	0.000221	CbGpPWpGaD
Everolimus—MTOR—Immune System—EP300—salivary gland cancer	0.000193	0.000211	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—AQP1—salivary gland cancer	0.000189	0.000207	CbGpPWpGaD
Everolimus—MTOR—Disease—PTEN—salivary gland cancer	0.000187	0.000204	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—CREBBP—salivary gland cancer	0.000183	0.0002	CbGpPWpGaD
Everolimus—MTOR—Disease—EP300—salivary gland cancer	0.000178	0.000195	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—PIK3CA—salivary gland cancer	0.000164	0.000179	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—TP53—salivary gland cancer	0.000159	0.000174	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—HRAS—salivary gland cancer	0.000152	0.000166	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—NUP62—salivary gland cancer	0.00015	0.000164	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—VCAN—salivary gland cancer	0.000149	0.000162	CbGpPWpGaD
Everolimus—MTOR—Immune System—PIK3CA—salivary gland cancer	0.000143	0.000156	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—CCND1—salivary gland cancer	0.000136	0.000148	CbGpPWpGaD
Everolimus—MTOR—Immune System—HRAS—salivary gland cancer	0.000132	0.000144	CbGpPWpGaD
Everolimus—MTOR—Disease—PIK3CA—salivary gland cancer	0.000132	0.000144	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—PTEN—salivary gland cancer	0.000131	0.000143	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—EP300—salivary gland cancer	0.000125	0.000136	CbGpPWpGaD
Everolimus—MTOR—Disease—HRAS—salivary gland cancer	0.000122	0.000133	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—PIK3CA—salivary gland cancer	9.24e-05	0.000101	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—TP53—salivary gland cancer	8.93e-05	9.76e-05	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—HRAS—salivary gland cancer	8.54e-05	9.33e-05	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—CREBBP—salivary gland cancer	5.81e-05	6.35e-05	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—PTEN—salivary gland cancer	4.15e-05	4.54e-05	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—EP300—salivary gland cancer	3.96e-05	4.33e-05	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—PIK3CA—salivary gland cancer	2.93e-05	3.2e-05	CbGpPWpGaD
